Gene · 3984
Papers2,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LIM kinase/inhibitor binding study in cell lysates using microscale thermophoresis in the red spectrum. | Anal Chim Acta | 2026 | 41330671 | PubTator, text mining | PubMed |
| Noncoding RNAs orchestrating the central dogma. | J Biol Chem | 2026 | 41242393 | PubTator, text mining | PubMed |
| Redox regulation of cell migration via Nischarin S-glutathionylation. | Free Radic Biol Med | 2026 | 41213437 | PubTator, text mining | PubMed |
| KLF7 enhances the inflammatory response in LPS-induced alveolar epithelial cells via activating the LIMK1/SRPK1 pathway. | Cent Eur J Immunol | 2025 | 42028385 | PubTator, text mining | PubMed |
| Rational design and structural Bioinformatics-Driven discovery of tetrapeptide inhibitors for LIMK-Targeted cancer therapy. | Med Oncol | 2025 | 41452532 | PubTator, text mining | PubMed |
| Neuronal Actin Remodeling and Its Role in Higher Nervous Activity. | Int J Mol Sci | 2025 | 41303700 | PubTator, text mining | PubMed |
| NSC23766 effectively inhibited retinal neovascularization by disrupting the positive feedback loop between Rac1 and VEGFR2. | Sci Rep | 2025 | 41266474 | PubTator, text mining | PubMed |
| Loss of p190A RhoGAP induces aneuploidy and enhances bladder cancer cell migration and invasion by modulating actin dynamics. | Sci Rep | 2025 | 41253923 | PubTator, text mining | PubMed |
Vasoactivity of Rac GTPase, Cytohesin and Kinase Inhibitors in Renal Interlobar and Coronary Arteries Reveals Shared and Distinct Patterns of Inhibitory Effects in Vascular and Prostate Smooth Muscle Contraction. | Pharmacol Res Perspect | 2025 | 41252219 | PubTator, text mining | PubMed |
| P21-activated kinase 4: a potent oncogene, molecular mechanisms and opportunities for targeted therapy. | Cancer Cell Int | 2025 | 41250149 | PubTator, text mining | PubMed |
| Exploring diarylheptanoid derivatives to target LIMK1 as potential agents against colorectal cancer. | J Enzyme Inhib Med Chem | 2025 | 41246964 | PubTator, text mining | PubMed |
| Redox Regulation of Cell Migration via Nischarin S-glutathionylation. | bioRxiv | 2025 | 41040280 | PubTator, text mining | PubMed |
| Repurposing Cofilin-Targeting Compounds for Ischemic Stroke Through Cheminformatics and Network Pharmacology. | Pharmaceuticals (Basel) | 2025 | 41011194 | PubTator, text mining | PubMed |
| LIMK1 is a prognosis and treatment biomarker in hepatocellular carcinoma. | Sci Rep | 2025 | 41006440 | PubTator, text mining | PubMed |
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
| Tension-sensitive LINC-RhoA signaling prevents chromatin bridge breakage in cytokinesis. | EMBO J | 2025 | 40926124 | PubTator, text mining | PubMed |
| Integrin β3 dysregulation impairs megakaryopoiesis and microparticle production via disrupting Rho-associated protein kinase-dependent cytoskeletal dynamics. | J Thromb Haemost | 2025 | 40915574 | PubTator, text mining | PubMed |
| At the Pointy End of Mechanobiology: AFM for Transient Biomechanical Analysis. | Adv Healthc Mater | 2025 | 40847732 | PubTator, text mining | PubMed |
| Identification of endothelial INSR as an osteosarcoma-related biomarker and therapeutic target based on weighted gene co-expression network analysis. | Discov Oncol | 2025 | 40846806 | PubTator, text mining | PubMed |
| Identification of actin cytoskeleton organization genes in oral cancer and oral potentially malignant disorders using oral tissue RNA-seq database. | Med Oral Patol Oral Cir Bucal | 2025 | 40818124 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3984/papers?page=3